CLINICAL_TRIALS ClinicalTrials.gov record update

Reactogenicity and Safety of Two Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus Vaccine, Rotarix™ When Administered in Sri Lankan Infants Aged at Least 6 Weeks at the Time of First Vaccination.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00779779
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:49.482959+00:00
Published At: 2010-07-30T00:00:00+00:00
Record Updated At: 2018-08-28
Results Posted At: 2010-07-30
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Infections, Rotavirus"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-08-28"
protocolSection.identificationModule.nctId: "NCT00779779"
protocolSection.identificationModule.officialTitle: "Reactogenicity and Safety of Two Doses of GSK Biologicals\u0027 Oral Live Attenuated Human Rotavirus Vaccine, Rotarix\u2122 When Administered in Sri Lankan Infants Aged at Least 6 Weeks at the Time of First Vaccination."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2010-07-30"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.